SUMMARY Patients with ankylosing spondylitis, psoriatic arthritis, and psoriasis alone were typed for HLA A, B, Cw, and DR antigens, and the antigen frequencies were compared with those in a normal control population and in patients with rheumatoid arthritis. Patients with psoriasis had a significantly raised frequency of Cw6. Those with arthritis in addition to their psoriasis also had raised frequencies of B27 and DR7. Patients with ankylosing spondylitis were characterised by the expected high frequency of HLA B27. Again, those with peripheral arthritis had a higher B27 and DR7 frequency than those without. DR3 is associated with the development of erosions in psoriatic arthritis.
The major histocompatibility complex (MHC) on human chromosome 6 codes for a variety of products whose common feature is an intimate involvement in the immune response. Genes determining HLA antigens form an important part of the MHC and have attracted considerable attention because of the association between certain antigens and a variety of diseases.' In particular, various arthropathies are linked to products of the MHC, the strongest known association being that between HLA B27 and ankylosing spondylitis (AS). 23 There was initial disappointment at not finding an association between rheumatoid arthritis and an HLA A or B antigen, but 2 groups later simultaneously described an association with HLA DR4. 4 The link between a disease and a given HLA antigen is not absolute, however. Not all patients possess the antigen, and only a minority of individuals with the antigen will develop the disease. This has led to speculation that a closely linked gene may predispose to development of the disease, perhaps through determining a particular type of immune response to an environmental agent. The phenomenon of linkage disequilibrium provides some theoretical support for this idea.
Psoriatic arthropathy (PsA) and ankylosing spondylitis are often included with ). This over-shadows all other changes in HLA frequency, and there is no significant difference with respect to this antigen between patients with and without arthritis, though it is higher in the latter group. Antigens showing a significant increase in all patients with psoriasis were Al (p<0001), B13 (p<0O01), and B17 (p<0.001), while B12 was significantly decreased (p<0001). Those antigens showing a significant increase in only those patients with arthritis were B27 (p<0.01) and DR7 (p<0 05). HLA Aw3O was increased in patients without arthritis, and the frequency of A10 was not significantly altered. The frequency of HLA DR4 was not raised in the group with arthritis.
In Table 2 are shown similar details for patients with ankylosing spondylitis. The expected very high prevalence of B27 was observed (81-8% overall). Also significantly increased were DR1 and DR2 (p<005). There was no significant difference between the subgroups with and without peripheral arthritis, though Al was significantly lower in those with peripheral arthritis than in normal controls (p<005). In this subgroup DR3 was much lower (5-6%) than in normal persons (28 4%), but the difference did not achieve statistical significance. B27 and DR7 occurred more frequently in those with HLA antigen frequencies of the patients with peripheral arthritis than in those without. In Table 3 we show comparative figures for patients with psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, and normal individuals. In psoriatic and rheumatoid arthritis there is an increase in Al, and in the latter group this is in association with B8, these 2 HLA antigens being in linkage disequilibrium. Although all groups share some reduction in B12, this is significant only in patients with psoriatic arthritis.
Analysis of clinical details of the groups of patients yielded little additional information, but there was a striking difference between patients with and without erosions in the psoriatic group (Table 4) . Six of the 15 patients with erosions possessed HLA DR3 in contrast to none of 9 without erosions. This was not statistically significant because of the small numbers available for analysis. Also shown are the numbers with and without sacroiliitis. As might be expected, more of those with sacroiliitis than without it were B27-positive. As [2] [3] [4] [5] it is perhaps surprising that not more attention has been paid to this antigen. Our patients appeared to be similar to others in their group.bmj.com on June 27, 2017 -Published by http://ard.bmj.com/ Downloaded from increased possession of Al, B13, and B17 and the decrease in B12.
More striking was the increase in Cw6. A report from the 8th Histocompatibility Workshop"5 described a significant association between psoriasis and DR7 and posed the question whether the primary association of the disease is with Cw6 or DR7. Our results indicate very strongly that the primary association of psoriasis is with Cw6. Of the 25 patients without psoriatic arthritis who were Cw locus typed, 21 were Cw6-positive but only 8 had DR7. The HLA B27 frequency was lowered in this group, and the rise of Al, B13, and B17 could all be ascribed to the high Cw6 frequency. In those psoriatic patients with arthritis DR7, Cw6, and B27 were significantly raised. These patients' results are very similar to those reported for Caucasoid patients in the 8th Workshop Study,'5 and in that report the majority were English and appear to have had arthritis. Thus, our results indicate that Cw6 is the primary association with psoriasis and that DR7 is an additional marker for psoriatic arthritis.
If we assume this to be so, then from the known linkage disequilibrium between Cw6 and A locus antigens2" we would expect Al and AW30 to be raised and A3, A9, Al0, and A28 to be lowered. This is almost what happens with the exception of A10 (A26 is a 'split' of A10), which is increased slightly but not significantly (other results not shown). This is in keeping with other reports."6 18 In the B series we would also assume B13 and B37 to be raised and B7, B8, B12, and B27 to be lowered. In practice B13 but not B37 is raised and B12 is very significantly lowered. HLA B27 is indeed lowered in the psoriasisalone group. In the patients with psoriatic arthritis B27 but not DR4 is raised, suggesting that their peripheral arthritis is more akin to that in other forms of seronegative spondarthritis than to rheumatoid arthritis.
One other HLA association is of particular note. Of the psoriatic arthritis patients with erosions (15) 6 had DR3 while none of the 9 without erosions possessed this antigen.
As mentioned previously, our results are very similar to those of the 8th Histocompatibility Workshop report" but differ considerably in some respects from those of Murray et al. 8 The significance of such alterations in histocompatibility antigens in these conditions is as yet a matter for speculation. Our findings argue against the idea that DR4 is a nonspecific marker for peripheral arthritis and suggest that it is fairly specific for RA. In ankylosing spondylitis opinion is sharply divided as to whether the B27 antigen itself is crucial to the disease process-for example, by 'molecular mimicry '26- 
